Pan-HDAC inhibitors sensitize melanoma cells to TRAIL-induced death by down-regulating the inhibitory c-FLIP, increasing expression of TRAIL receptors such as DR4 and DR5 and shifting in expression of apoptotic proteins towards a state more permissive to apoptosis [92,94,99,154,155]. Here, HDAC9 is linked to melanoma.